We do not display all the achieved goals on the graph, you can get detailed information about the achieved goals in the corresponding section on this page
Stock ticker: | MRK |
Name: | MERCK & CO., INC. |
Sector: | Healthcare |
Investing Risk: | HIGH |
Forecast length: | 9 days |
Accuracy: | 58.49 % |
Average profit per target: | 9.85 % |
Signal Date | Signal Price | Date Reached | Price Reached | Profit | Direction |
---|---|---|---|---|---|
2022-04-27 | 76.69 $ | 2022-11-22 | 98.71 $ | 28.71% | |
2022-05-05 | 79.96 $ | 2022-12-14 | 103.69 $ | 29.67% | |
2022-05-06 | 80.31 $ | 2022-12-14 | 103.69 $ | 29.11% | |
2022-05-09 | 79.63 $ | 2022-12-14 | 103.69 $ | 30.22% | |
2022-05-10 | 79.78 $ | 2022-12-14 | 103.69 $ | 29.96% | |
2022-05-11 | 81.04 $ | 2022-12-14 | 103.69 $ | 27.95% | |
2022-05-12 | 82.53 $ | 2022-12-08 | 102.36 $ | 24.03% | |
2022-05-13 | 82.14 $ | 2022-12-08 | 102.36 $ | 24.61% | |
2022-05-16 | 83.88 $ | 2022-12-08 | 102.36 $ | 22.03% | |
2022-05-17 | 84.5 $ | 2022-11-28 | 100.14 $ | 18.52% | |
2022-05-18 | 83.68 $ | 2022-11-25 | 99.27 $ | 18.62% | |
2022-05-25 | 85.18 $ | 2022-12-14 | 103.69 $ | 21.73% | |
2022-06-01 | 82.81 $ | 2022-11-28 | 100.14 $ | 20.93% | |
2022-06-03 | 81.69 $ | 2022-11-22 | 98.71 $ | 20.84% | |
2022-06-07 | 82.21 $ | 2022-11-28 | 100.14 $ | 21.82% | |
2022-06-08 | 81.3 $ | 2022-11-28 | 100.14 $ | 23.18% | |
2022-06-10 | 79.21 $ | 2022-12-14 | 103.69 $ | 30.9% | |
2022-06-13 | 77.23 $ | 2022-12-14 | 103.69 $ | 34.26% | |
2022-06-14 | 77.4 $ | 2023-01-06 | 106.75 $ | 37.91% | |
2022-06-15 | 77.52 $ | 2023-01-06 | 106.75 $ | 37.7% | |
2022-06-16 | 77.76 $ | 2023-01-06 | 106.75 $ | 37.28% | |
2022-06-17 | 77.51 $ | 2023-01-06 | 106.75 $ | 37.71% | |
2022-06-21 | 80.64 $ | 2023-01-06 | 106.75 $ | 32.38% | |
2022-06-23 | 84.27 $ | 2023-01-05 | 105.63 $ | 25.34% | |
2022-06-28 | 84.17 $ | 2023-04-13 | 108.18 $ | 28.52% | |
2022-07-07 | 85.2 $ | 2023-05-02 | 110.34 $ | 29.51% | |
2023-07-03 | 107.73 $ | 2024-03-27 | 126.69 $ | 17.6% | |
2023-09-05 | 101.3 $ | 2024-01-29 | 115.89 $ | 14.4% | |
2024-12-24 | 97.62 $ | 2025-02-06 | 86.43 $ | 11.46% | |
2024-12-31 | 97.65 $ | 2025-02-06 | 86.43 $ | 11.49% | |
2025-03-04 | 90.86 $ | 2025-04-16 | 75.7 $ | 16.68% | |
2025-03-07 | 92.91 $ | 2025-05-14 | 72.74 $ | 21.71% | |
2025-03-11 | 92.99 $ | 2025-05-14 | 72.74 $ | 21.77% | |
2025-03-27 | 86.73 $ | 2025-05-14 | 72.74 $ | 16.13% |
MRK Merck & Co., Inc. has recently received FDA approval to expand the use of its top-selling drug Keytruda. This news has led to positive expectations for the company's future performance....
Merck & Co., Inc. (MRK) has been recognized as one of the top dividend contenders in the market, according to Yahoo Finance....
Merck Co. Inc. (MRK) has emerged as a top pick among investors looking for stable and reliable stocks....
Shareholders that lost money on Merck & Co. Inc. (MRK) are being urged to join a class action against the company....
Merck & Co., Inc., commonly known as Merck, has emerged as one of the most undervalued stocks in the US market, as indicated by leading hedge funds....
Merck & Co. (MRK), one of the leading pharmaceutical companies, has announced the opening of its state-of-the-art $1 billion Next-Generation Vaccine Facility....
Merck & Co., Inc., commonly known as Merck, is a global healthcare company that develops and markets innovative pharmaceutical, vaccine, biologic, and animal health products....
Merck & Co., Inc. (MRK) is set to present its strategic update at the upcoming TD Cowen Healthcare Conference....
Investors of MRK Merck & Co. Inc. have been urged by ROSEN HIGHLY RECOGNIZED INVESTOR COUNSEL to seek legal representation before the critical deadline related to a securities class action....
Merck & Co., Inc. (NYSE: MRK) has caught the attention of investors as a potential investment opportunity....